Seer Inc

SEER

$1.61

Closing

▲1.26%

1D

▼-17.01%

YTD

SEER

BBG00HPLTRS7

Market cap

$98.29M

52 week high

$2.63

52 week low

$1.46

Volume

41,770

Check if the stock is halal

Unlock Industry-grade Shariah Compliance for global stocks. See results from 5 major Shariah standards: AAOIFI, S&P, DJIM, FTSE and MSCI.

We provide unparalleled value and service.
Screened by AAOIFI Certified Shariah Advisor & Auditor.

Get started from just $6.99/month

Market cap

$98.29M

Analysts' Rating

HOLD

Price Target (Mean)

3.00

Total Analysts

3

P/E

Operating Margin

-882.03%

Beta

1.42

Revenue Growth

-23.35%

52 week high

$2.63

52 week low

$1.46

Div. Yield

%

EPS Growth

9.31

Company Profile

Seer, Inc. is a life sciences company. The Company is engaged in developing transformative products that open a new gateway to the proteome. Its product, the Proteograph Product Suite (Proteograph), leverages its proprietary engineered nanoparticle (NP) technology to provide unbiased, deep, rapid and large-scale access to the proteome. The Proteograph Product Suite is an integrated solution that includes consumables, an automation instrument and software. Its proprietary engineered NPs provide unbiased sampling of intact proteins across the dynamic range of the proteome, capturing molecular information at the peptide-level, including protein variants. It is focused on driving the adoption of the Proteograph by customers in the proteomics and genomics markets. The Proteograph Product Suite is an integrated solution consisting of consumables, an automation instrument, and software to perform biased, deep proteomic analysis at scale in a matter of hours.